Samil Pharmaceutical Co.,Ltd (KRX:000520)
10,830
+50 (0.46%)
Last updated: Jun 5, 2025
KRX:000520 Revenue
Samil Pharmaceutical Co.,Ltd had revenue of 52.29B KRW in the quarter ending March 31, 2025, a decrease of -3.70%. This brings the company's revenue in the last twelve months to 217.69B, up 6.24% year-over-year. In the year 2024, Samil Pharmaceutical Co.,Ltd had annual revenue of 219.70B with 11.89% growth.
Revenue (ttm)
217.69B
Revenue Growth
+6.24%
P/S Ratio
1.06
Revenue / Employee
373.39M
Employees
583
Market Cap
229.92B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 219.70B | 23.35B | 11.89% |
Dec 31, 2023 | 196.35B | 16.67B | 9.28% |
Dec 31, 2022 | 179.68B | 45.43B | 33.84% |
Dec 31, 2021 | 134.25B | 11.25B | 9.14% |
Dec 31, 2020 | 123.00B | 1.89B | 1.56% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |